Federal Circuit Affirms Ruling in Decapolis Systems v. Epic Systems Healthcare Patent Dispute

📄 View Full Report 📥 Export PDF 🔗 Share ⭐ Save

📋 Case Summary

Case NameDecapolis Systems, LLC v. Epic Systems, Corp.
Case Number23-1302 (Fed. Cir.)
CourtCourt of Appeals for the Federal Circuit, District of Columbia
DurationDec 29, 2022 – Apr 4, 2024 462 days
OutcomeDefendant Win — Appeal Dismissed
Patents at Issue
Accused ProductsEpic’s apparatus and method implementations for processing and providing healthcare information and healthcare-related information

Case Overview

The Parties

⚖️ Plaintiff

A patent assertion entity pursuing licensing and litigation around healthcare information system technologies, operating without a disclosed commercial product footprint.

🛡️ Defendant

One of the largest and most widely deployed electronic health records (EHR) software companies in the United States, serving major hospital systems and healthcare providers.

Patents at Issue

This litigation centered on two patents covering apparatus and methods for processing and providing healthcare information — technology at the heart of modern electronic health record (EHR) systems. These patents address foundational methods for managing, processing, and distributing healthcare data.

  • US7490048B2 — Covering apparatus and methods for processing healthcare information
  • US7464040B2 — Covering systems for providing healthcare-related information
🔍

Developing healthcare IT solutions?

Check if your system might infringe these or related patents before deployment.

Run FTO Check →

The Verdict & Legal Analysis

Outcome

The Federal Circuit issued a clean affirmance of the lower court’s ruling: “THIS CAUSE having been considered, it is ORDERED AND ADJUDGED: AFFIRMED.” The appeal was subsequently dismissed, terminating the litigation in favor of Epic Systems. This outcome signals the durability of the underlying ruling and reinforces critical considerations for healthcare software patent assertion strategies.

Key Legal Issues

The Federal Circuit’s affirmance indicates that the appellate panel found no reversible error in the lower court’s analysis. In healthcare IT patent litigation, infringement actions frequently turn on claim construction — specifically, how broadly or narrowly terms like “processing healthcare information” are construed. The affirmance here suggests the claim construction and/or infringement analysis survived appellate scrutiny intact, reinforcing the difficulty of sustaining broad infringement claims against mature EHR platforms.

⚠️

Freedom to Operate (FTO) Analysis in Healthcare IT

This case highlights critical IP risks in healthcare information technology. Choose your next step:

📋 Understand This Case’s Impact

Learn about the specific risks and implications from this litigation for healthcare IT.

  • View all related patents in healthcare information processing
  • See which companies are most active in EHR patents
  • Understand claim construction patterns in software patents
📊 View Patent Landscape
⚠️
High Risk Area

Legacy data processing patents (pre-2005)

📋
50+ Related Patents

In healthcare IT/EHR space

Strong Defense Found

Against broad claims for Epic

✅ Key Takeaways

For Patent Attorneys & Litigators

The Federal Circuit affirmed the lower ruling, dismissing the appeal in full, reinforcing the defensibility of mature EHR platforms.

Search related case law →

Healthcare IT patent claims covering information processing methods face rigorous claim construction scrutiny at both trial and appellate levels.

Explore claim construction trends →

Defense record quality at the district court level is determinative of Federal Circuit affirmance likelihood in complex technology disputes.

Analyze litigation strategies →
🔒
Unlock R&D Team Recommendations
Get actionable IP strategy steps for healthcare IT product teams, including FTO timing guidance and design-around best practices for software.
FTO Timing Guidance Software Claim Strategy IP Risk Mitigation
Explore Full Analysis in PatSnap Eureka

Frequently Asked Questions

Ready to Strengthen Your Patent Strategy?

Join 18,000+ IP professionals using PatSnap Eureka to conduct prior art searches, draft patents, and analyse competitive landscapes with AI-powered precision.

PatSnap IP Intelligence Team

Patent Research & Competitive Intelligence · PatSnap

This analysis was produced by the PatSnap IP Intelligence Team — a group of patent analysts, IP strategists, and data scientists who work daily with PatSnap’s global patent database of over 2 billion structured data points across patents, litigation records, scientific literature, and regulatory filings.

The team specialises in tracking landmark litigation outcomes, translating complex court rulings into actionable IP strategy, and identifying the competitive intelligence implications for R&D and legal teams. All case analysis is grounded in primary sources: official court records, USPTO filings, and Federal Circuit opinions.

📊 2B+ Patent Data Points 🌍 120+ Countries Covered 🏢 18,000+ Customers Worldwide ⚖️ Global Litigation Database 🔍 Primary Source Verified
⚖️ Disclaimer: This article is for informational purposes only and does not constitute legal advice. The analysis presented reflects publicly available case information and general legal principles. For specific advice regarding patent litigation, FTO analysis, or IP strategy, please consult a qualified patent attorney.